Shift in cytotoxic target from estrogen receptor-positive to estrogen receptor-negative breast cancer cells by trastuzumab in combination with taxane-based chemotherapy

類似資料

• Ki-67 as a prognostic marker according to breast cancer subtype and a predictor of recurrence time in primary breast cancer
  著者:: NISHIMURA, REIKI, 等
  出版事項: (2010)
• Ki-67 index value and progesterone receptor status can predict prognosis and suitable treatment in node-negative breast cancer patients with estrogen receptor-positive and HER2-negative tumors
  著者:: Arima, Nobuyuki, 等
  出版事項: (2019)
• Predictive significance of the proportion of ER-positive or PgR-positive tumor cells in response to neoadjuvant chemotherapy for operable HER2-negative breast cancer
  著者:: OSAKO, TOMOFUMI, 等
  出版事項: (2012)
• Changes in the ER, PgR, HER2, p53 and Ki-67 biological markers between primary and recurrent breast cancer: discordance rates and prognosis
  著者:: Nishimura, Reiki, 等
  出版事項: (2011)
• Triple Negative Breast Cancer: An Analysis of the Subtypes and the Effects of Menopausal Status on Invasive Breast Cancer
  著者:: Reiki Nishimura, 等
  出版事項: (2022-04-01)